Amino Acids Interfere with the ERK1/2-dependent Control of Macroautophagy by Controlling the Activation of Raf-1 in Human Colon Cancer HT-29 Cells
Overview
Affiliations
Activation of ERK1/2 stimulates macroautophagy in the human colon cancer cell line HT-29 by favoring the phosphorylation of the Galpha-interacting protein (GAIP) in an amino acid-dependent manner (Ogier-Denis, E., Pattingre, S., El Benna, J., and Codogno, P. (2000) J. Biol. Chem. 275, 39090-39095). Here we show that ERK1/2 activation by aurintricarboxylic acid (ATA) treatment induces the phosphorylation of GAIP in an amino acid-dependent manner. Accordingly, ATA challenge increased the rate of macroautophagy, whereas epidermal growth factor did not significantly affect macroautophagy and GAIP phosphorylation status. In fact, ATA activated the ERK1/2 signaling pathway, whereas epidermal growth factor stimulated both the ERK1/2 pathway and the class I phosphoinositide 3-kinase pathway, known to decrease the rate of macroautophagy. Amino acids interfered with the ATA-induced macroautophagy by inhibiting the activation of the kinase Raf-1. The role of the Ras/Raf-1/ERK1/2 signaling pathway in the GAIP- and amino acid-dependent control of macroautophagy was confirmed in HT-29 cells expressing the Ras(G12V,T35S) mutant. Similar to the protein phosphatase 2A inhibitor okadaic acid, amino acids sustained the phosphorylation of Ser(259), which is involved in the negative regulation of Raf-1. In conclusion, these results add a novel target to the amino acid signaling-dependent control of macroautophagy in intestinal cells.
Wang X, Li S, Lin S, Han Y, Zhan T, Huang Z Cell Res. 2025; .
PMID: 40055523 DOI: 10.1038/s41422-025-01085-9.
Loss of TC-PTP in keratinocytes leads to increased UVB-induced autophagy.
Asare O, Shim L, Lee C, Delgado J, Quailes N, Zavala K Cell Death Discov. 2025; 11(1):80.
PMID: 40021617 PMC: 11871011. DOI: 10.1038/s41420-025-02353-8.
Ferdousmakan S, Mansourian D, Seyedi Asl F, Fathi Z, Maleki-Sheikhabadi F, Nabi Afjadi M Med Oncol. 2025; 42(3):62.
PMID: 39899220 DOI: 10.1007/s12032-025-02607-6.
Mirza Z, Karim S Cells. 2024; 13(17.
PMID: 39273044 PMC: 11394487. DOI: 10.3390/cells13171474.
ERK2 Is a Promoter of Cancer Cell Growth and Migration in Colon Adenocarcinoma.
Parascandolo A, Benincasa G, Corcione F, Laukkanen M Antioxidants (Basel). 2024; 13(1).
PMID: 38247543 PMC: 10812609. DOI: 10.3390/antiox13010119.